DE3876997D1 - Konjugate von superoxiddismutase. - Google Patents

Konjugate von superoxiddismutase.

Info

Publication number
DE3876997D1
DE3876997D1 DE8888907489T DE3876997T DE3876997D1 DE 3876997 D1 DE3876997 D1 DE 3876997D1 DE 8888907489 T DE8888907489 T DE 8888907489T DE 3876997 T DE3876997 T DE 3876997T DE 3876997 D1 DE3876997 D1 DE 3876997D1
Authority
DE
Germany
Prior art keywords
disismutase
superoxide
conjugates
superoxide disismutase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888907489T
Other languages
English (en)
Other versions
DE3876997T2 (de
Inventor
Mark Saifer
Ralph Somack
David Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DDI Pharmaceuticals Inc
Original Assignee
DDI Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DDI Pharmaceuticals Inc filed Critical DDI Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3876997D1 publication Critical patent/DE3876997D1/de
Publication of DE3876997T2 publication Critical patent/DE3876997T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8888907489T 1987-08-03 1988-07-29 Konjugate von superoxiddismutase. Expired - Fee Related DE3876997T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8100987A 1987-08-03 1987-08-03
PCT/US1988/002530 WO1989001033A1 (en) 1987-08-03 1988-07-29 Conjugates of superoxide dismutase

Publications (2)

Publication Number Publication Date
DE3876997D1 true DE3876997D1 (de) 1993-02-04
DE3876997T2 DE3876997T2 (de) 1993-04-29

Family

ID=22161332

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888907489T Expired - Fee Related DE3876997T2 (de) 1987-08-03 1988-07-29 Konjugate von superoxiddismutase.

Country Status (17)

Country Link
EP (1) EP0377613B1 (de)
JP (1) JP2515389B2 (de)
KR (1) KR920001426B1 (de)
CN (1) CN1020458C (de)
AU (1) AU608901B2 (de)
CA (1) CA1309046C (de)
DE (1) DE3876997T2 (de)
DK (1) DK160842C (de)
ES (1) ES2007536A6 (de)
HU (1) HU203783B (de)
IE (1) IE64284B1 (de)
IL (1) IL87177A (de)
NZ (1) NZ225481A (de)
PH (1) PH27225A (de)
RU (1) RU1776275C (de)
WO (1) WO1989001033A1 (de)
ZA (1) ZA885249B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893439B1 (de) * 1989-04-19 2005-07-27 Enzon, Inc. Verfahren zum Herstellen von modifizierten Polypeptiden die eine Polypeptid und ein Polyalkylenoxid enthalten
US5109118A (en) * 1989-07-06 1992-04-28 Yutaka Mizushima Modified biologically active proteins
GB8919661D0 (en) * 1989-08-31 1989-10-11 Univ Alberta Superoxide dismutase-catalase conjugates
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
WO1993002701A1 (en) * 1991-08-05 1993-02-18 Sterling Winthrop Inc. Buffered formulation of peg-sod
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
US5349001A (en) * 1993-01-19 1994-09-20 Enzon, Inc. Cyclic imide thione activated polyalkylene oxides
US5516703A (en) * 1993-08-20 1996-05-14 The University Of Utah Coating of hydrophobic surfaces to render them protein resistant while permitting covalent attachment of specific ligands
US6284503B1 (en) 1993-08-20 2001-09-04 University Of Utah Research Foundation Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces
WO1999067370A1 (en) * 1998-06-23 1999-12-29 Novozymes A/S A polypeptide-polymer conjugate
US6638526B1 (en) 1998-06-23 2003-10-28 Novozymes A/S Polypeptides conjugated to copolymers of ethylene oxide and propylene oxide to reduce allergenicity
JP2002520049A (ja) * 1998-07-17 2002-07-09 ノボザイムス アクティーゼルスカブ 改良された洗浄性能を有するポリペプチド−ポリマー接合体
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US20040062748A1 (en) 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
BR0317742A (pt) 2002-12-26 2005-11-22 Mountain View Pharmaceuticals Conjugados poliméricos de interferon-beta com potência biológica aumentada
EP1626983B8 (de) 2003-05-12 2010-12-22 Affymax, Inc. Neue poly(ethylenglycol) modifizierte erythropoietinagonisten und deren verwendungen
CN108445106A (zh) * 2018-04-11 2018-08-24 南京明捷生物医药检测有限公司 一种药物中消泡剂聚丙二醇残留的检测方法
CN108864309B (zh) * 2018-07-26 2021-07-13 广州暨南大学医药生物技术研究开发中心有限公司 重组人sod-生长因子融合蛋白、其制备方法及其应用
CN109112119B (zh) * 2018-08-28 2022-04-26 佛山科学技术学院 经化学修饰的鸭血sod制剂的制备方法
CN117551625B (zh) * 2024-01-12 2024-03-08 山东爱维德生物科技有限公司 一种用于木立芦荟sod胶的聚乙二醇二胺-海藻酸改性sod酶及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL74177A (en) * 1984-02-03 1989-09-10 Abbott Lab Stabilized enzyme conjugate composition containing a calcium salt and a polyethylene glycol
GB8430252D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
GB8430253D0 (en) * 1984-11-30 1985-01-09 Beecham Group Plc Compounds
JPH084504B2 (ja) * 1985-04-26 1996-01-24 味の素株式会社 安定化ス−パ−オキサイドジスムタ−ゼ

Also Published As

Publication number Publication date
WO1989001033A1 (en) 1989-02-09
JPH02504341A (ja) 1990-12-13
DK160842C (da) 1991-10-14
HUT52816A (en) 1990-08-28
KR920001426B1 (ko) 1992-02-13
IE882206L (en) 1989-02-03
DE3876997T2 (de) 1993-04-29
AU608901B2 (en) 1991-04-18
NZ225481A (en) 1990-11-27
CN1020458C (zh) 1993-05-05
RU1776275C (ru) 1992-11-15
DK160842B (da) 1991-04-22
DK392789D0 (da) 1989-08-10
KR890701736A (ko) 1989-12-21
EP0377613B1 (de) 1992-12-23
AU2326888A (en) 1989-03-01
PH27225A (en) 1993-05-04
IL87177A0 (en) 1988-12-30
IL87177A (en) 1992-08-18
JP2515389B2 (ja) 1996-07-10
ZA885249B (en) 1989-04-26
IE64284B1 (en) 1995-07-26
HU203783B (en) 1991-09-30
CA1309046C (en) 1992-10-20
EP0377613A1 (de) 1990-07-18
CN1031088A (zh) 1989-02-15
ES2007536A6 (es) 1989-06-16
DK392789A (da) 1989-08-10

Similar Documents

Publication Publication Date Title
DE3876997D1 (de) Konjugate von superoxiddismutase.
DE3853504D1 (de) Modifiziertes beta-Chinacridon-Pigment.
FI873619A0 (fi) Rf-skyddad hybridkrets.
NO881658D0 (no) Bifunksjonelle proteiner.
DE3789807T2 (de) Kosmetikum.
FI891296A0 (fi) Kompatibelt bredskaermstelevisionssystem.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DE3783916T2 (de) Externer fixateur.
NO872815L (no) Leket.
FI873060A0 (fi) Modifierad vaevnads-plasmin-aktivator.
FI880443A (fi) Ljushaerdande hartssammansaettning.
DK495188D0 (da) Ekspressionsvektor
FI874117A0 (fi) Belysningssystem.
FI881724A (fi) Saorfoerband.
FI880587A0 (fi) Eldslaeckningsapparat.
FI874005A0 (fi) Tuvbildande skogskultivator.
DE3769515D1 (de) Anhaenger.
KR890700354A (ko) 향지성제
DE3881393T2 (de) Dehydrobromierung von substituiertem alpha-halocumol.
FI873673A (fi) Vaermevaexlare.
FI872130A0 (fi) Foerbaettringar avseende skyddsplaot foer byggnader.
IT8711556V0 (it) Scocca elevabile.
DK110787D0 (da) Konjugater
ES1005923Y (es) Pendiente mejorado
FI883463A0 (fi) Anordning foer undervattensarbete.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee